To confirm the clinical significance regarding the mevalonate pathway-dependent regulation of FoxM1 in human HCC, we finally examined the expressions of FoxM1 and the mevalonate pathway-related genes in tumor tissues of HCC patients, whose clinicopathological features are summarized in Table 1. Here, FOXM1 is linked to hepatocellular carcinoma.